Sarepta Therapeutics Inc (NASDAQ:SRPT)

63.91
Delayed Data
As of 4:00pm ET
 +0.90 / +1.43%
Today’s Change
28.14
Today|||52-Week Range
68.90
+14.86%
Year-to-Date
BioMarin (BMRN) Q4 Loss Wider Than Expected, Sales Beat
10:03am / Zacks.com - Paid Partner Content
Sound Familiar? Dovish Fed Talk Induces Stock Reversal
Feb 22 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close63.01
Today’s open63.87
Day’s range61.88 - 64.00
Volume975,751
Average volume (3 months)1,702,723
Market cap$4.1B
Data as of 4:00pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)-5.58%
Earnings growth (this year)+86.01%
Earnings growth (next 5 years)+0.37%
Revenue growth (last year)+332.64%
P/E ratioNM
Price/Sales246.40
Price/Book10.25

Competitors

 Today’s
change
Today’s
% change
CBPOChina Biologic Produ...+1.46+1.74%
MDCOMedicines Co+1.24+4.16%
GWPHGW Pharmaceuticals P...-1.96-1.67%
PBHPrestige Brands Hold...+0.15+0.43%
Data as of 4:02pm ET, 02/23/2018

Financials

Last reporting date--
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$5.4M
Annual profit (last year)-$267.3M
Net profit margin-4,930.18%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Douglas S. Ingram
Executive VP, Chief Financial &
Business Officer
Sandesh Mahatme
Corporate headquarters
Cambridge, Massachusetts

Forecasts